GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hyperfine Inc (NAS:HYPR) » Definitions » Days Sales Outstanding

Hyperfine (Hyperfine) Days Sales Outstanding : 95.56 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Hyperfine Days Sales Outstanding?

Hyperfine's average Accounts Receivable for the three months ended in Dec. 2023 was $2.81 Mil. Hyperfine's Revenue for the three months ended in Dec. 2023 was $2.69 Mil. Hence, Hyperfine's Days Sales Outstanding for the three months ended in Dec. 2023 was 95.56.

The historical rank and industry rank for Hyperfine's Days Sales Outstanding or its related term are showing as below:

HYPR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 71.14   Med: 88.12   Max: 216.02
Current: 97.24

During the past 5 years, Hyperfine's highest Days Sales Outstanding was 216.02. The lowest was 71.14. And the median was 88.12.

HYPR's Days Sales Outstanding is ranked worse than
77.57% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 64.66 vs HYPR: 97.24

Hyperfine's Days Sales Outstanding declined from Dec. 2022 (153.95) to Dec. 2023 (95.56).


Hyperfine Days Sales Outstanding Historical Data

The historical data trend for Hyperfine's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyperfine Days Sales Outstanding Chart

Hyperfine Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
- 216.02 88.69 71.14 87.54

Hyperfine Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 153.95 88.67 94.00 125.03 95.56

Competitive Comparison of Hyperfine's Days Sales Outstanding

For the Medical Devices subindustry, Hyperfine's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hyperfine's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hyperfine's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Hyperfine's Days Sales Outstanding falls into.



Hyperfine Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Hyperfine's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (2.103 + 3.189) / 2 ) / 11.032*365
=2.646 / 11.032*365
=87.54

Hyperfine's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (2.437 + 3.189) / 2 ) / 2.686*365 / 4
=2.813 / 2.686*365 / 4
=95.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hyperfine  (NAS:HYPR) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Hyperfine Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Hyperfine's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Hyperfine (Hyperfine) Business Description

Traded in Other Exchanges
N/A
Address
351 New Whitfield Street, Guilford, CT, USA, 06437
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. Legacy Hyperfine and Liminal represent two operating segments of the company. The company derives its sales from the following sources: 1) device sales which consist of sales of MRI devices and 2) service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.
Executives
Thomas Teisseyre officer: Chief Operating Officer C/O HYPERFINE, INC., 351 NEW WHITFIELD STREET, GUILFORD CT 06437
Khan Siddiqui officer: See Remarks 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Brett Hale officer: Chief Administrative Officer C/O HYPERFINE, INC., 351 NEW WHITFIELD STREET, GUILFORD CT 06437
Maria Sainz director C/O ORTHOFIX INTERNATIONAL N. V., 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Jonathan M Rothberg director, 10 percent owner C/O BUTTERFLY NETWORK, INC., 530 OLD WHITFIELD ST., GUILFORD CT 06437
Alok Gupta officer: Chief Financial Officer 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Neela Paykel officer: Gen Counsel & Corp Secretary 530 OLD WHITFIELD STREET, GUILFORD CT 06437
David D Scott director, officer: President and CEO 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Ruth A Fattori director 1303 EAST ALGONQUIN ROAD, SCHAUMBURG IL 60196
Hc Sponsor Llc 10 percent owner 31 HUDSON YARDS, 10TH FLOOR, 28TH FLOOR, NEW YORK NY 10001
Arthur Bruce Cohen 10 percent owner 12 SOUTH MAIN STREET, SUITE #203, NORWALK CT 06854
Healthcor Group, Llc 10 percent owner 31 HUDSON YARDS, 10TH FLOOR, NEW YORK NY 10001
Joseph Patrick Healey 10 percent owner 31 HUDSON YARDS, 10TH FLOOR, NEW YORK NY 10001
R Scott Huennekens director C/O VOLCANO CORPORATION, 11455 EL CAMINO REAL, SUITE 460, SAN DIEGO CA 92130
Scott A. White officer: Chief Commercial Officer 530 OLD WHITFIELD STREET, GUILFORD CT 06437

Hyperfine (Hyperfine) Headlines